A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
5.03 +0.00 (0.00%) OSIR

Click Here to Receive Instant E-mail and RSS Alerts


Trade OSIR now with

Stock Details

Last Trade:5.03 Change:+0.00 (0.00%) Prev Close:5.03 Open: 5.92 Days Range:4.73 – 5.92 52 Week Range: 4.12 - 8.39 Volume:295664 P/E: 11.70
EPS:0.43





Recent Blog Posts

Blog Posts on 01/18/12 at 12:14pm
5 Risky Biotech Stocks To Avoid, 2 To Consider
Blog Posts on 01/05/12 at 8:43am
Osiris Shows No Reason To Invest In Stem Cell Ideas
Blog Posts on 12/28/11 at 10:43am
Sirus XM: Year In Review And 2012 Outlook
Blog Posts on 11/11/11 at 3:20pm
Regenerative Medicine Universe Earnings Report Card Q3/11
Blog Posts on 08/30/11 at 11:30am
RegMed Daily Dialogue 8/29/11: Post Excessive Sell-Off, September Is Still In The Wind
Blog Posts on 08/24/11 at 11:41am
Regenerative Medicine Companies Trading At Huge Discounts
Blog Posts on 08/11/11 at 9:42am
Earnings Report Card, Regenerative Medicine Universe Edition
Blog Posts on 06/27/11 at 2:14pm
Is Big Pharma Really Trying to Cure Diabetes? We're Seeking Profits and Debunking Myths
Blog Posts on 06/12/11 at 4:14am
6 Stock to Consider on Insider Buying Reported This Week
Blog Posts on 04/13/11 at 3:27pm
Companies Positioned for Treating Acute Radiation Syndrome
Blog Posts on 04/12/11 at 12:50pm
25 Small Caps With Sales and EPS Declining in 2012
Blog Posts on 03/14/11 at 1:23pm
Earthquake Highlights Opportunity for Treating Radiation Sickness
Blog Posts on 02/15/11 at 5:14pm
Beware the Lady Gaga Effect on Growth or Rebound Stocks
Blog Posts on 01/30/11 at 3:09am
Osiris: Finding Opportunity Amongst Uncertainty
Blog Posts on 01/27/11 at 10:52am
Osiris: Opportunity Amidst Uncertainty
Blog Posts on 08/25/10 at 3:41am
Court Decision Puts Pressure on Embryonic Stem Cell Stocks
Blog Posts on 08/25/10 at 3:04am
Stem Cell Competition Heating Up
Blog Posts on 07/21/10 at 11:28am
Three Trades on FDA, Clinical Trial Binary Events
Blog Posts on 05/07/10 at 2:40pm
Osiris Therapeutics, Inc. Q1 2010 Earnings Call Transcript
Blog Posts on 01/12/10 at 3:49am
Joe Feshbach's Highest Conviction Position: A Regenerative Medicine 'Game Changer'
Blog Posts on 01/04/10 at 3:37am
Biotech’s 2009 Stealth Small Cap Rally
Blog Posts on 12/10/09 at 4:55am
Graft-Versus-Host Disease: Failures and Future Opportunities
Blog Posts on 11/20/09 at 6:26pm
Expiration Trade Behind Osiris Activity
Blog Posts on 11/03/09 at 3:53pm
Tuesday Options Recap
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Blog Posts on 09/11/09 at 5:49am
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Blog Posts on 09/08/09 at 4:24pm
Closing Update: Stocks String Together 3 Straight Wins, Commodities Gain
Blog Posts on 08/27/09 at 9:36am
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 2
Blog Posts on 08/27/09 at 9:35am
Cryo-Cell: The Stem Cell Sector's Profit Leader, Part 1
Blog Posts on 08/25/09 at 9:55am
'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers